Report Detail

Pharma & Healthcare Global Glycopyrrolate Injection Market Growth 2022-2028

  • RnM4439216
  • |
  • 12 May, 2022
  • |
  • Global
  • |
  • 121 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

As the global economy mends, the 2021 growth of Glycopyrrolate Injection will have significant change from previous year. According to our (LP Information) latest study, the global Glycopyrrolate Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Glycopyrrolate Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Glycopyrrolate Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Glycopyrrolate Injection market, reaching US$ million by the year 2028. As for the Europe Glycopyrrolate Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Glycopyrrolate Injection players cover Accord Healthcare, Advanz Pharma, American Regent, and Amneal Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Glycopyrrolate Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.2mg/ml
0.4mg/2ml
1mg/5ml
4mg/20ml

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Accord Healthcare
Advanz Pharma
American Regent
Amneal Pharmaceuticals
Apotex
BE Pharmaceuticals
BluePoint Laboratories
Caplin Steriles
Civica
Fresenius Kabi
Gland Pharma
Hikma
Khandelwal Laboratories
Meitheal
Nivagen Pharmaceuticals
NorthStar Rx
Sandoz
Solco Healthcare
SteriMax
Xiromed
AuroMedics Pharma
Par Pharmaceutical
Piramal Critical Care
Somerset Therapeutics
West-ward Pharmaceutical
Zydus Pharmaceuticals
Hengrui Pharmaceuticals
Jiabo Pharmaceutical
Easton Biopharmaceuticals


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Glycopyrrolate Injection Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Glycopyrrolate Injection by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Glycopyrrolate Injection by Country/Region, 2017, 2022 & 2028
  • 2.2 Glycopyrrolate Injection Segment by Type
    • 2.2.1 0.2mg/ml
    • 2.2.2 0.4mg/2ml
    • 2.2.3 1mg/5ml
    • 2.2.4 4mg/20ml
  • 2.3 Glycopyrrolate Injection Sales by Type
    • 2.3.1 Global Glycopyrrolate Injection Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Glycopyrrolate Injection Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Glycopyrrolate Injection Sale Price by Type (2017-2022)
  • 2.4 Glycopyrrolate Injection Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Clinics
    • 2.4.3 Others
  • 2.5 Glycopyrrolate Injection Sales by Application
    • 2.5.1 Global Glycopyrrolate Injection Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Glycopyrrolate Injection Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Glycopyrrolate Injection Sale Price by Application (2017-2022)

3 Global Glycopyrrolate Injection by Company

  • 3.1 Global Glycopyrrolate Injection Breakdown Data by Company
    • 3.1.1 Global Glycopyrrolate Injection Annual Sales by Company (2020-2022)
    • 3.1.2 Global Glycopyrrolate Injection Sales Market Share by Company (2020-2022)
  • 3.2 Global Glycopyrrolate Injection Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Glycopyrrolate Injection Revenue by Company (2020-2022)
    • 3.2.2 Global Glycopyrrolate Injection Revenue Market Share by Company (2020-2022)
  • 3.3 Global Glycopyrrolate Injection Sale Price by Company
  • 3.4 Key Manufacturers Glycopyrrolate Injection Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Glycopyrrolate Injection Product Location Distribution
    • 3.4.2 Players Glycopyrrolate Injection Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Glycopyrrolate Injection by Geographic Region

  • 4.1 World Historic Glycopyrrolate Injection Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Glycopyrrolate Injection Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Glycopyrrolate Injection Annual Revenue by Geographic Region
  • 4.2 World Historic Glycopyrrolate Injection Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Glycopyrrolate Injection Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Glycopyrrolate Injection Annual Revenue by Country/Region
  • 4.3 Americas Glycopyrrolate Injection Sales Growth
  • 4.4 APAC Glycopyrrolate Injection Sales Growth
  • 4.5 Europe Glycopyrrolate Injection Sales Growth
  • 4.6 Middle East & Africa Glycopyrrolate Injection Sales Growth

5 Americas

  • 5.1 Americas Glycopyrrolate Injection Sales by Country
    • 5.1.1 Americas Glycopyrrolate Injection Sales by Country (2017-2022)
    • 5.1.2 Americas Glycopyrrolate Injection Revenue by Country (2017-2022)
  • 5.2 Americas Glycopyrrolate Injection Sales by Type
  • 5.3 Americas Glycopyrrolate Injection Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Glycopyrrolate Injection Sales by Region
    • 6.1.1 APAC Glycopyrrolate Injection Sales by Region (2017-2022)
    • 6.1.2 APAC Glycopyrrolate Injection Revenue by Region (2017-2022)
  • 6.2 APAC Glycopyrrolate Injection Sales by Type
  • 6.3 APAC Glycopyrrolate Injection Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Glycopyrrolate Injection by Country
    • 7.1.1 Europe Glycopyrrolate Injection Sales by Country (2017-2022)
    • 7.1.2 Europe Glycopyrrolate Injection Revenue by Country (2017-2022)
  • 7.2 Europe Glycopyrrolate Injection Sales by Type
  • 7.3 Europe Glycopyrrolate Injection Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Glycopyrrolate Injection by Country
    • 8.1.1 Middle East & Africa Glycopyrrolate Injection Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Glycopyrrolate Injection Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Glycopyrrolate Injection Sales by Type
  • 8.3 Middle East & Africa Glycopyrrolate Injection Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Glycopyrrolate Injection
  • 10.3 Manufacturing Process Analysis of Glycopyrrolate Injection
  • 10.4 Industry Chain Structure of Glycopyrrolate Injection

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Glycopyrrolate Injection Distributors
  • 11.3 Glycopyrrolate Injection Customer

12 World Forecast Review for Glycopyrrolate Injection by Geographic Region

  • 12.1 Global Glycopyrrolate Injection Market Size Forecast by Region
    • 12.1.1 Global Glycopyrrolate Injection Forecast by Region (2023-2028)
    • 12.1.2 Global Glycopyrrolate Injection Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Glycopyrrolate Injection Forecast by Type
  • 12.7 Global Glycopyrrolate Injection Forecast by Application

13 Key Players Analysis

  • 13.1 Accord Healthcare
    • 13.1.1 Accord Healthcare Company Information
    • 13.1.2 Accord Healthcare Glycopyrrolate Injection Product Offered
    • 13.1.3 Accord Healthcare Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Accord Healthcare Main Business Overview
    • 13.1.5 Accord Healthcare Latest Developments
  • 13.2 Advanz Pharma
    • 13.2.1 Advanz Pharma Company Information
    • 13.2.2 Advanz Pharma Glycopyrrolate Injection Product Offered
    • 13.2.3 Advanz Pharma Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Advanz Pharma Main Business Overview
    • 13.2.5 Advanz Pharma Latest Developments
  • 13.3 American Regent
    • 13.3.1 American Regent Company Information
    • 13.3.2 American Regent Glycopyrrolate Injection Product Offered
    • 13.3.3 American Regent Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 American Regent Main Business Overview
    • 13.3.5 American Regent Latest Developments
  • 13.4 Amneal Pharmaceuticals
    • 13.4.1 Amneal Pharmaceuticals Company Information
    • 13.4.2 Amneal Pharmaceuticals Glycopyrrolate Injection Product Offered
    • 13.4.3 Amneal Pharmaceuticals Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Amneal Pharmaceuticals Main Business Overview
    • 13.4.5 Amneal Pharmaceuticals Latest Developments
  • 13.5 Apotex
    • 13.5.1 Apotex Company Information
    • 13.5.2 Apotex Glycopyrrolate Injection Product Offered
    • 13.5.3 Apotex Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Apotex Main Business Overview
    • 13.5.5 Apotex Latest Developments
  • 13.6 BE Pharmaceuticals
    • 13.6.1 BE Pharmaceuticals Company Information
    • 13.6.2 BE Pharmaceuticals Glycopyrrolate Injection Product Offered
    • 13.6.3 BE Pharmaceuticals Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 BE Pharmaceuticals Main Business Overview
    • 13.6.5 BE Pharmaceuticals Latest Developments
  • 13.7 BluePoint Laboratories
    • 13.7.1 BluePoint Laboratories Company Information
    • 13.7.2 BluePoint Laboratories Glycopyrrolate Injection Product Offered
    • 13.7.3 BluePoint Laboratories Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 BluePoint Laboratories Main Business Overview
    • 13.7.5 BluePoint Laboratories Latest Developments
  • 13.8 Caplin Steriles
    • 13.8.1 Caplin Steriles Company Information
    • 13.8.2 Caplin Steriles Glycopyrrolate Injection Product Offered
    • 13.8.3 Caplin Steriles Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Caplin Steriles Main Business Overview
    • 13.8.5 Caplin Steriles Latest Developments
  • 13.9 Civica
    • 13.9.1 Civica Company Information
    • 13.9.2 Civica Glycopyrrolate Injection Product Offered
    • 13.9.3 Civica Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Civica Main Business Overview
    • 13.9.5 Civica Latest Developments
  • 13.10 Fresenius Kabi
    • 13.10.1 Fresenius Kabi Company Information
    • 13.10.2 Fresenius Kabi Glycopyrrolate Injection Product Offered
    • 13.10.3 Fresenius Kabi Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Fresenius Kabi Main Business Overview
    • 13.10.5 Fresenius Kabi Latest Developments
  • 13.11 Gland Pharma
    • 13.11.1 Gland Pharma Company Information
    • 13.11.2 Gland Pharma Glycopyrrolate Injection Product Offered
    • 13.11.3 Gland Pharma Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Gland Pharma Main Business Overview
    • 13.11.5 Gland Pharma Latest Developments
  • 13.12 Hikma
    • 13.12.1 Hikma Company Information
    • 13.12.2 Hikma Glycopyrrolate Injection Product Offered
    • 13.12.3 Hikma Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Hikma Main Business Overview
    • 13.12.5 Hikma Latest Developments
  • 13.13 Khandelwal Laboratories
    • 13.13.1 Khandelwal Laboratories Company Information
    • 13.13.2 Khandelwal Laboratories Glycopyrrolate Injection Product Offered
    • 13.13.3 Khandelwal Laboratories Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Khandelwal Laboratories Main Business Overview
    • 13.13.5 Khandelwal Laboratories Latest Developments
  • 13.14 Meitheal
    • 13.14.1 Meitheal Company Information
    • 13.14.2 Meitheal Glycopyrrolate Injection Product Offered
    • 13.14.3 Meitheal Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Meitheal Main Business Overview
    • 13.14.5 Meitheal Latest Developments
  • 13.15 Nivagen Pharmaceuticals
    • 13.15.1 Nivagen Pharmaceuticals Company Information
    • 13.15.2 Nivagen Pharmaceuticals Glycopyrrolate Injection Product Offered
    • 13.15.3 Nivagen Pharmaceuticals Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Nivagen Pharmaceuticals Main Business Overview
    • 13.15.5 Nivagen Pharmaceuticals Latest Developments
  • 13.16 NorthStar Rx
    • 13.16.1 NorthStar Rx Company Information
    • 13.16.2 NorthStar Rx Glycopyrrolate Injection Product Offered
    • 13.16.3 NorthStar Rx Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.16.4 NorthStar Rx Main Business Overview
    • 13.16.5 NorthStar Rx Latest Developments
  • 13.17 Sandoz
    • 13.17.1 Sandoz Company Information
    • 13.17.2 Sandoz Glycopyrrolate Injection Product Offered
    • 13.17.3 Sandoz Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.17.4 Sandoz Main Business Overview
    • 13.17.5 Sandoz Latest Developments
  • 13.18 Solco Healthcare
    • 13.18.1 Solco Healthcare Company Information
    • 13.18.2 Solco Healthcare Glycopyrrolate Injection Product Offered
    • 13.18.3 Solco Healthcare Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.18.4 Solco Healthcare Main Business Overview
    • 13.18.5 Solco Healthcare Latest Developments
  • 13.19 SteriMax
    • 13.19.1 SteriMax Company Information
    • 13.19.2 SteriMax Glycopyrrolate Injection Product Offered
    • 13.19.3 SteriMax Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.19.4 SteriMax Main Business Overview
    • 13.19.5 SteriMax Latest Developments
  • 13.20 Xiromed
    • 13.20.1 Xiromed Company Information
    • 13.20.2 Xiromed Glycopyrrolate Injection Product Offered
    • 13.20.3 Xiromed Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.20.4 Xiromed Main Business Overview
    • 13.20.5 Xiromed Latest Developments
  • 13.21 AuroMedics Pharma
    • 13.21.1 AuroMedics Pharma Company Information
    • 13.21.2 AuroMedics Pharma Glycopyrrolate Injection Product Offered
    • 13.21.3 AuroMedics Pharma Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.21.4 AuroMedics Pharma Main Business Overview
    • 13.21.5 AuroMedics Pharma Latest Developments
  • 13.22 Par Pharmaceutical
    • 13.22.1 Par Pharmaceutical Company Information
    • 13.22.2 Par Pharmaceutical Glycopyrrolate Injection Product Offered
    • 13.22.3 Par Pharmaceutical Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.22.4 Par Pharmaceutical Main Business Overview
    • 13.22.5 Par Pharmaceutical Latest Developments
  • 13.23 Piramal Critical Care
    • 13.23.1 Piramal Critical Care Company Information
    • 13.23.2 Piramal Critical Care Glycopyrrolate Injection Product Offered
    • 13.23.3 Piramal Critical Care Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.23.4 Piramal Critical Care Main Business Overview
    • 13.23.5 Piramal Critical Care Latest Developments
  • 13.24 Somerset Therapeutics
    • 13.24.1 Somerset Therapeutics Company Information
    • 13.24.2 Somerset Therapeutics Glycopyrrolate Injection Product Offered
    • 13.24.3 Somerset Therapeutics Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.24.4 Somerset Therapeutics Main Business Overview
    • 13.24.5 Somerset Therapeutics Latest Developments
  • 13.25 West-ward Pharmaceutical
    • 13.25.1 West-ward Pharmaceutical Company Information
    • 13.25.2 West-ward Pharmaceutical Glycopyrrolate Injection Product Offered
    • 13.25.3 West-ward Pharmaceutical Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.25.4 West-ward Pharmaceutical Main Business Overview
    • 13.25.5 West-ward Pharmaceutical Latest Developments
  • 13.26 Zydus Pharmaceuticals
    • 13.26.1 Zydus Pharmaceuticals Company Information
    • 13.26.2 Zydus Pharmaceuticals Glycopyrrolate Injection Product Offered
    • 13.26.3 Zydus Pharmaceuticals Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.26.4 Zydus Pharmaceuticals Main Business Overview
    • 13.26.5 Zydus Pharmaceuticals Latest Developments
  • 13.27 Hengrui Pharmaceuticals
    • 13.27.1 Hengrui Pharmaceuticals Company Information
    • 13.27.2 Hengrui Pharmaceuticals Glycopyrrolate Injection Product Offered
    • 13.27.3 Hengrui Pharmaceuticals Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.27.4 Hengrui Pharmaceuticals Main Business Overview
    • 13.27.5 Hengrui Pharmaceuticals Latest Developments
  • 13.28 Jiabo Pharmaceutical
    • 13.28.1 Jiabo Pharmaceutical Company Information
    • 13.28.2 Jiabo Pharmaceutical Glycopyrrolate Injection Product Offered
    • 13.28.3 Jiabo Pharmaceutical Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.28.4 Jiabo Pharmaceutical Main Business Overview
    • 13.28.5 Jiabo Pharmaceutical Latest Developments
  • 13.29 Easton Biopharmaceuticals
    • 13.29.1 Easton Biopharmaceuticals Company Information
    • 13.29.2 Easton Biopharmaceuticals Glycopyrrolate Injection Product Offered
    • 13.29.3 Easton Biopharmaceuticals Glycopyrrolate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.29.4 Easton Biopharmaceuticals Main Business Overview
    • 13.29.5 Easton Biopharmaceuticals Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Glycopyrrolate Injection. Industry analysis & Market Report on Glycopyrrolate Injection is a syndicated market report, published as Global Glycopyrrolate Injection Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Glycopyrrolate Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,650.00
$7,320.00
3,025.85
6,068.28
3,500.35
7,019.88
494,538.50
991,786.80
288,277.00
578,133.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report